SCHEMBL14612136

SCHEMBL14612136

CCCCC(CCCCCC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
TNF P01375 2/20 0.46
TLR2 O60603 4/20 0.45
KDM4E B2RXH2 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HDAC8 Q9BY41 5/20 0.41
HDAC3 O15379 3/20 0.41
HDAC6 Q9UBN7 3/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC4 P56524 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
FABP5 Q01469 3/20 0.40
FABP7 O15540 2/20 0.40
PTGES O14684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21182260 0.93 KDM4E (0.46) KMT2ATNFTLR2KDM4ETSHR
SCHEMBL16773475 0.87 TLR2 (0.46) KMT2ATNFTLR2FABP5FABP7
SCHEMBL16360194 0.87 KMT2A (0.54) KMT2ATNFTLR2FABP5FABP7
SCHEMBL27984222 0.87 KMT2A (0.54) KMT2ATNFTLR2FABP5FABP7
Hydrochloric Acid SCHEMBL28086829 0.85 KMT2A (0.53) KMT2ATNFTLR2FABP5FABP7
SCHEMBL14612149 0.85 KMT2A (0.52) KMT2ATNFTLR2FABP5FABP7
SCHEMBL10071038 0.84 KMT2A (0.50) KMT2ATNFTLR2KDM4EFABP5
SCHEMBL14759878 0.83 KMT2A (0.60) KMT2ATNFFABP5FABP7
SCHEMBL14237194 0.82 KMT2A (0.51) KMT2ATNFTLR2HDAC1HDAC2
SCHEMBL7705059 0.82 KMT2A (0.51) KMT2ATNFTLR2HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7179918-B2 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis AGOURON PHARMACEUTICALS, INC. (US) 2007-02-20 US disclosed